CIK: 0001595851 · Show all filings
Period: Q3 2020 (← Previous) (Next →)
Filing Date: Nov 16, 2020
Total Value: $346M (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Share Price | Est. Cost/Share | Unrealized @ Report Date | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|---|
| XBI | SPDR SER TR | 451,000 | $50.26M | 14.5% | $111.43 | — | — | Put | 78464A870 |
| — | TRILLIUM THERAPEUTICS INC | 1,950,000 | $27.71M | 8.0% | $14.21 | $7.71 | — | COM NEW | 89620X506 |
| ASND | ASCENDIS PHARMA A/S | 130,000 | $20.06M | 5.8% | $154.32 | $130.34 | — | SPONSORED ADR | 04351P101 |
| — | MERSANA THERAPEUTICS INC | 1,050,000 | $19.55M | 5.7% | $18.62 | $10.98 | — | COM | 59045L106 |
| IOVA | IOVANCE BIOTHERAPEUTICS INC | 575,000 | $18.93M | 5.5% | $32.92 * | $24.73 | +23.9% | COM | 462260100 |
| IMVT | IMMUNOVANT INC | 525,000 | $18.48M | 5.3% | $35.19 * | $11.17 | +169.3% | COM | 45258J102 |
| — | CONSTELLATION PHARMCETICLS I | 725,000 | $14.69M | 4.2% | $20.26 | $42.72 | — | COM | 210373106 |
| — | ADVERUM BIOTECHNOLOGIES INC | 1,161,375 | $11.96M | 3.5% | $10.30 | $6.88 | — | COM | 00773U108 |
| — | MIRATI THERAPEUTICS INC | 60,000 | $9.963M | 2.9% | $166.05 | $82.63 | — | COM | 60468T105 |
| ALDX | ALDEYRA THERAPEUTICS INC | 1,250,000 | $9.263M | 2.7% | $7.41 * | $4.21 | +53.3% | COM | 01438T106 |
| RCKT | ROCKET PHARMACEUTICALS INC | 400,000 | $9.144M | 2.6% | $22.86 * | $15.79 | +56.0% | COM | 77313F106 |
| SRPT | SAREPTA THERAPEUTICS INC | 65,000 | $9.128M | 2.6% | $140.43 * | $151.97 | 0.0% | COM | 803607100 |
| FOLD | AMICUS THERAPEUTICS INC | 600,000 | $8.472M | 2.4% | $14.12 * | $14.57 | 0.0% | COM | 03152W109 |
| AUPH | AURINIA PHARMACEUTICALS INC | 550,000 | $8.102M | 2.3% | $14.73 | $11.07 | +30.9% | COM | 05156V102 |
| FATE | FATE THERAPEUTICS INC | 200,000 | $7.994M | 2.3% | $39.97 * | $25.07 | +39.3% | COM | 31189P102 |
| — | SURFACE ONCOLOGY INC | 1,000,000 | $6.9M | 2.0% | $6.90 | $6.66 | — | COM | 86877M209 |
| KURA | KURA ONCOLOGY INC | 225,000 | $6.894M | 2.0% | $30.64 * | $22.08 | 0.0% | COM | 50127T109 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 1,950,000 | $6.698M | 1.9% | $3.43 * | $4.33 | -1.1% | COM | 09058V103 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 425,000 | $6.273M | 1.8% | $14.76 * | $12.69 | +20.1% | COM | 87164F105 |
| AGIO | AGIOS PHARMACEUTICALS INC | 175,000 | $6.125M | 1.8% | $35.00 * | $45.46 | -3.6% | COM | 00847X104 |
| — | IVERIC BIO INC | 1,000,000 | $5.64M | 1.6% | $5.64 | $7.63 | — | COM | 46583P102 |
| TGTX | TG THERAPEUTICS INC | 200,000 | $5.352M | 1.5% | $26.76 * | $14.42 | +59.6% | COM | 88322Q108 |
| — | VERONA PHARMA PLC | 805,556 | $5.027M | 1.5% | $6.24 | $6.24 | — | SPONSORED ADS | 925050106 |
| IMUX | IMMUNIC INC | 265,000 | $4.921M | 1.4% | $18.57 * | $16.38 | 0.0% | COM | 4525EP101 |
| ARVN | ARVINAS INC | 200,000 | $4.722M | 1.4% | $23.61 * | $27.91 | +3.8% | COM | 04335A105 |
| KALV | KALVISTA PHARMACEUTICALS INC | 350,000 | $4.407M | 1.3% | $12.59 | $15.74 | -20.6% | COM | 483497103 |
| — | AVADEL PHARMACEUTICALS PLC | 825,000 | $4.158M | 1.2% | $5.04 | $8.02 | — | SPONSORED ADR | 05337M104 |
| — | RAPT THERAPEUTICS INC | 115,000 | $3.703M | 1.1% | $32.20 | $32.20 | — | COM | 75382E109 |
| WVE | WAVE LIFE SCIENCES LTD | 425,000 | $3.608M | 1.0% | $8.49 * | $9.41 | +16.5% | SHS | Y95308105 |
| XENE | XENON PHARMACEUTICALS INC | 325,000 | $3.598M | 1.0% | $11.07 * | $14.24 | -17.4% | COM | 98420N105 |
| — | NEXTCURE INC | 400,000 | $3.52M | 1.0% | $8.80 | $8.80 | — | COM | 65343E108 |
| — | MYOVANT SCIENCES LTD | 250,000 | $3.513M | 1.0% | $14.05 | $13.68 | — | COM | G637AM102 |
| — | REATA PHARMACEUTICALS INC | 30,000 | $2.923M | 0.8% | $97.43 | $121.68 | — | CL A | 75615P103 |
| ALT | ALTIMMUNE INC | 200,000 | $2.64M | 0.8% | $13.20 * | $9.12 | +119.2% | COM NEW | 02155H200 |
| RGNX | REGENXBIO INC | 75,000 | $2.064M | 0.6% | $27.52 * | $32.60 | 0.0% | COM | 75901B107 |
| — | MILLENDO THERAPEUTICS INC | 925,000 | $1.508M | 0.4% | $1.63 | $1.63 | — | COM | 60040X103 |
| — | HOMOLOGY MEDICINES INC | 135,000 | $1.445M | 0.4% | $10.70 | $15.49 | — | COM | 438083107 |
| — | IMV INC | 325,000 | $1.443M | 0.4% | $4.44 | $4.44 | — | COM | 44974L103 |
| BIIB | BIOGEN INC | 4,200 | $1.191M | 0.3% | $283.57 | $278.91 | 0.0% | COM | 09062X103 |
| — | GRAYBUG VISION INC | 75,000 | $953K | 0.3% | $12.71 | $12.71 | — | COM SHS | 38942Q103 |
| — | SATSUMA PHARMACEUTICALS INC | 200,000 | $778K | 0.2% | $3.89 | $26.31 | — | COM | 80405P107 |
| MRNA | MODERNA INC | 10,000 | $708K | 0.2% | $70.80 | $54.76 | +27.3% | COM | 60770K107 |
| AKBA | AKEBIA THERAPEUTICS INC | 250,000 | $628K | 0.2% | $2.51 * | $8.78 | 0.0% | COM | 00972D105 |
| — | AMARIN CORP PLC | 100,000 | $421K | 0.1% | $4.21 | $4.21 | — | SPONS ADR NEW | 023111206 |
| — | BRISTOL-MYERS SQUIBB CO | 125,000 | $281K | 0.1% | $2.25 | $2.25 | — | RIGHT 99/99/9999 | 110122157 |
| — | CHEMOCENTRYX INC | 4,500 | $247K | 0.1% | $54.89 | $54.89 | — | COM | 16383L106 |